First Hospital of Shanxi Medical University
Taiyuan, Shanxi, China
Hospital in Taiyuan
Shanxi, Taiyuan, Yingze District, 解放南路85号 邮政编码 - 030012
About First Hospital of Shanxi Medical University
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Beijing Friendship Hospital
6
Reistone Biopharma Company Limited
6
Beijing Tiantan Hospital
5
Second Hospital of Shanxi Medical University
5
Beijing Chao Yang Hospital
4
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
4
Jiangsu Simcere Pharmaceutical Co., Ltd.
4
Capital Medical University
3
Eli Lilly and Company
3
Jiangsu HengRui Medicine Co., Ltd.
3
Peking University Third Hospital
3
Clinical Trials at First Hospital of Shanxi Medical University
During the past decade, First Hospital of Shanxi Medical University conducted 121 clinical trials. In the 10-year time frame, 121 clinical trials started and 12 clinical trials were completed, i.e. on
average, 9.9% percent of trials that started reached the finish line to date. In the past 5 years, 68 clinical trials started and 8 clinical trials were completed. i.e. 11.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Nadroparin for the Initial Treatment of Pulmonary Thromboembolism
2002-06-01
2006-02-01
Completed
274
12-h and 2-h Urokinase Regimes of Pulmonary Thromboembolism in China
2002-06-01
2006-02-01
Completed
129
Recombinant Streptokinase Versus Urokinase in Pulmonary Embolism in China (RESUPEC)
2006-06-01
2009-05-01
Completed
83
A Study to Evaluate the Efficacy of Teprenone On Chinese Patients With Chronic Non-Atrophic Erosive Gastritis
2011-02-01
2013-06-01
Completed
156
A Study of Rheumatoid Arthritis Treatment With Enbrel in Adult Patient in Outpatient Department
2011-01-01
2013-01-01
Terminated
160
Low Dose Rt-PA for Acute Normotensive Pulmonary Embolism With RVD
2009-07-01
2012-12-01
Unknown status
460
The Diagnosis and Treatment of Resistant Hypertension, the Prevalence and the Prognosis
2012-07-01
2018-12-01
Unknown status
9,638
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "First Hospital of Shanxi Medical University" #1 sponsor was "Beijing Friendship Hospital" with 6 trials, followed by "Reistone Biopharma Company Limited" with 6 trials
sponsored, "Beijing Tiantan Hospital" with 5 trials sponsored, "Second Hospital of Shanxi Medical University" with 5 trials sponsored and "Beijing Chao Yang Hospital"
with 5 trials sponsored. Other sponsors include 120 different institutions and
companies that sponsored additional 93 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "First Hospital of Shanxi Medical University"
#1 collaborator was "The First Affiliated Hospital of Shanxi Medical University" with 13 trials as a collaborator, "Peking University First Hospital" with 9 trials as a collaborator, "Second Hospital of Shanxi Medical University" with 9 trials as a collaborator, "Peking Union Medical College Hospital" with 7 trials as a collaborator and "Tang-Du Hospital" with 7 trials as a collaborator. Other collaborators include 491 different institutions and companies that were
collaborators in the rest 280 trials.
Clinical Trials Conditions at First Hospital of Shanxi Medical University
According to Clinical.Site data, the most researched conditions in "First Hospital of Shanxi Medical University" are
"Acute Ischemic Stroke" (5 trials), "Hypertension" (4 trials), "Pulmonary Embolism" (4 trials), "Type 2 Diabetes" (4 trials) and "Alzheimer Disease" (3 trials). Many other conditions were trialed in "First Hospital of Shanxi Medical University" in a lesser frequency.
Clinical Trials Intervention Types at First Hospital of Shanxi Medical University
Most popular intervention types in "First Hospital of Shanxi Medical University" are "Drug" (109 trials), "Biological" (12 trials), "Other" (11 trials), "Device" (7 trials) and "Procedure" (4 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (26 trials), "SHR0302" (4 trials), "Placebos" (3 trials), "placebo" (3 trials) and "Amlodipine besylate tablets" (2 trials). Other intervention names were less common.
Clinical Trials Genders at First Hospital of Shanxi Medical University
The vast majority of trials in "First Hospital of Shanxi Medical University" are
138 trials for "All" genders, 8 trials for "Male" genders and 5 trials for "Female" genders.
Clinical Trials Status at First Hospital of Shanxi Medical University
Currently, there are 62 active trials in "First Hospital of Shanxi Medical University".
7 are not yet recruiting,
41 are recruiting,
13 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 55 completed trials in First Hospital of Shanxi Medical University,
undefined suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in First Hospital of Shanxi Medical University, 10 "Phase 1"
clinical trials were conducted, 32 "Phase 2" clinical
trials and 45 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 27 trials, and there were
also 16 trials that are defined as “Not Applicable".